HR 1244

Summary

Reducing Drug Prices for Seniors Act This bill requires the coinsurance amount for covered drugs under the Medicare prescription drug benefit to be based on the actual acquisition cost of the drug (i.e., the negotiated price under the prescription drug plan net of any manufacturer price concessions), rather than the wholesale acquisition cost of the drug, if the actual acquisition cost is lower.

Bill status

Status

In committee

Sponsor

Rep. Donald G. Davis [D-NC-1]

Cosponsors

2

Policy area

Health

Introduced

2025-02-12

Latest action

2025-02-12: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee referrals

• Ways and Means Committee: House · Referred To · 2025-02-12
• Energy and Commerce Committee: House · Referred To · 2025-02-12

Recent actions

• 2025-02-12: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-02-12: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-02-12: Introduced in House
• 2025-02-12: Introduced in House